DUAL EPITHELIAL AND STROMAL TARGETING IN BREAST CANCER USING THE PHASE II ROCK2 INHIBITOR KD025 GUIDED BY INTRAVITAL IMAGING TECHNOLOGY
$555,506FY2022Department of the ArmyDOD
University Of New South Wales, Sydney
University Of New South Wales, Sydney